Connect public, paid and private patent data with Google Patents Public Datasets

Percutaneous valve prosthesis and system and method for implanting same

Download PDF

Info

Publication number
US20090306768A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
valve
stent
cage
leaflet
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US12309680
Inventor
Arshad Quadri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences CardiAQ LLC
Original Assignee
CardiAQ Valve Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436Deployment by retracting a sheath
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/2439Expansion controlled by filaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular

Abstract

A heart valve prosthesis includes a cylindrical valve cage stent constructed to be implanted percutaneously in the planar axis of a native valve annulus, an elastic and compressible, multi-leaflet valve insertable percutaneously into the body, and an attachment mechanism for attaching the valve to the superior rim of the valve cage stent. The valve can be of a bi-leaflet or a tri-leaflet type and includes a valve frame made from a memory metal and a tissue cover attached to the valve frame. The valve cage stent is self-expanding or balloon expandable, made respectively from memory metal or stainless steel but otherwise structurally the same.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • [0001]
    The present patent application is based on, and claims priority from, U.S. provisional Application No. 60/833,791, filed Jul. 28, 2006, which is incorporated herein by reference in its entirety.
  • BACKGROUND OF THE INVENTION
  • [0002]
    1. Field of the Invention
  • [0003]
    The present invention relates to heart valve prostheses, preferably to aortic valve prostheses. More specifically, the invention relates to heart valve prostheses that can be implanted percutaneously by means of a catheter from a remote Location without opening the chest cavity.
  • [0004]
    2. Related Art
  • [0005]
    Heart valve surgery is used to repair or replace diseased heart valves. Valve surgery is an open-heart procedure conducted under general anesthesia. An incision is made through the patient's sternum (sternotomy), and the patient's heart is stopped while blood flow is rerouted through a heart-lung bypass machine.
  • [0006]
    Valve replacement may be indicated when there is a narrowing of the native heart valve, commonly referred to as stenosis, or when the native valve leaks or regurgitates. When replacing the valve, the native valve is excised and replaced with either a biologic or a mechanical valve. Mechanical valves require lifelong anticoagulant medication to prevent clot formation around the valve, which can lead to thromboembolic complications and catastrophic valve failure. Biologic tissue valves typically do not require such medication. Tissue valves can be obtained from cadavers (homografts) or can be from pigs (porcine valve) and cows (bovine pericardial valves). Recently equine pericardium has also been used for making valves. These valves are designed to be attached to the patient using a standard surgical technique.
  • [0007]
    Valve replacement surgery is a highly invasive operation with significant concomitant risk. Risks include bleeding, infection, stroke, heart attack, arrhythmia, renal failure, and adverse reactions to the anesthesia medications, as well as sudden death. Two to five percent of patients die during surgery.
  • [0008]
    Post-surgery, patients temporarily may be confused due to emboli and other factors associated with the heart-lung machine. The first two to three days following surgery are spent in an intensive care unit where heart functions can be closely monitored. The average hospital stay is between one and two weeks, with several more weeks to months required for complete recovery.
  • [0009]
    In recent years, advancements in minimally invasive, endoaortic, surgery interventional cardiology, and intervention radiology have encouraged some investigators to pursue percutaneous replacement of the aortic heart valve. Percutaneous Valve Technologies (“PVT”) of Fort Lee, N. J., has developed a balloon-expandable stent integrated with a bioprosthetic valve, which is the subject of U.S. Pat. Nos. 5,411,552, 5,840,081, 6,168,614, and 6,582,462 to Anderson et al. The stent/valve device is deployed across the native diseased valve to permanently hold the valve open, thereby alleviating a need to excise the native valve and to position the bioprosthetic valve in place of the native valve. PVT's device is designed for delivery in a cardiac catheterization laboratory under local anesthesia using fluoroscopic guidance, thereby avoiding general anesthesia and open-heart surgery. The device was first implanted in a patient in April of 2002.
  • [0010]
    PVT's device suffers from several drawbacks. Deployment of PVT's stent has several drawbacks, including that there is very little control over its deployment. This lack of control can endanger the coronary ostea above the aortic valve and the anterior leaflet of the mitral valve below the aortic valve.
  • [0011]
    Another drawback of the PVT device is its relatively large cross-sectional delivery profile. This is largely due to fabricating the tri-leaflet pericardial valve inside a robust stainless steel stent. Considering they have to be durable, the materials for the valve and the stent are very bulky, thus increasing the profile of the device. The PVT system's stent/valve combination is mounted onto a delivery balloon, making retrograde delivery through the aorta challenging. An antegrade transseptal approach may therefore be needed, requiring puncture of the septum and routing through the mitral valve, which significantly increases complexity and risk of the procedure. Very few cardiologists are currently trained in performing a transseptal puncture, which is a challenging procedure by itself.
  • [0012]
    Another drawback of the PVT device is its lack of fixation provision. It in effect uses its radial force to hold the stent in the desired position. For this to work, sufficient dilatation of the valve area has to be achieved; but this amount of dilation can cause damage to the annulus. Also, due to its inability to have an active fixation mechanism, the PVT device cannot be used to treat aortic regurgitation.
  • [0013]
    Another drawback to this system is that it does not address the leakage of blood around the implant, after its implantation.
  • [0014]
    Other prior art replacement heart valves use self-expanding stents that incorporate a valve. One such device is that disclosed in U.S. Pat. No. 7,018,406 to Seguin et al. and assigned to and made by CoreValve SA. In the endovascular aortic valve replacement procedure, accurate placement of aortic valves relative to coronary ostia and the mitral valve is critical. Standard self-expanding systems have very poor accuracy in deployment, however. Often the proximal end of the stent is not released from the delivery system until accurate placement is verified by fluoroscopy and the stent typically jumps once released. It is therefore often impossible to know where the ends of the stent will be with respect to the native valve, the coronary ostia, and the mitral valve. The anchoring mechanism is not actively provided (that is, there is no method of fixation other than the use of radial force and barbs that project into the surrounding tissue and not used as positioning marker (that is, markers seen under fluoroscopy to determine the position of the device).
  • [0015]
    A simple barb as used in the CoreValve device relies mainly on friction for holding the position.
  • [0016]
    Another drawback of prior art self-expanding replacement heart valve systems is their lack of radial strength. In order for self-expanding systems to be easily delivered through a delivery sheath, the metal needs to flex and bend inside the delivery catheter without being plastically deformed. In arterial stents, this is not a challenge, and there are many commercial arterial stent systems that apply adequate radial force against the vessel wall and yet can collapse to a small enough of a diameter to fit inside a delivery catheter without plastically deforming. However, when the stent has a valve fastened inside it, as is the case in aortic valve replacement, the anchoring of the stent to vessel walls is significantly challenged during diastole. The force required to hold back arterial pressure and prevent blood from going back inside the ventricle during diastole will be directly transferred to the stent/vessel wall interface. Therefore the amount of radial force required to keep the self expanding stent/valve in contact with the vessel wall and prevent it from sliding will be much higher than in stents that do not have valves inside of them. Moreover, a self-expanding stent without sufficient radial force will end up dilating and contracting with each heartbeat, thereby distorting the valve, affecting its function and resulting in dynamic repositioning of the stent during delivery. Stent foreshortening or migration during expansion may lead to improper alignment.
  • [0017]
    Additionally, the stent disclosed in U.S. Pat. No. 6,425,916 to Garrison simply crushes the native valve leaflets against the heart wall and does not engage the leaflets in a manner that would provide positive registration of the device relative to the native position of the valve. This increases an immediate risk of blocking the coronary ostia, as well as a longer-term risk of migration of the device post-implantation. Further still, the stent comprises openings or gaps in which the replacement valve is seated post-delivery. Tissue may protrude through these gaps, thereby increasing a risk of improper seating of the valve within the stent.
  • [0018]
    In view of drawbacks associated with previously known techniques for endovascularly replacing a heart valve, it would be desirable to provide methods and apparatus that overcome those drawbacks.
  • [0019]
    Sadra et al. (U.S. published application No. 20050137701) describes a mechanism for anchoring a heart valve, the anchoring mechanism having an actuation system operated remotely. This mechanism addresses the fixation issue; however, considering the irregular shape of the aortic annulus there is a real potential for deforming the prosthetic valve annulus; this may require additional balloon angioplasty to give it its final shape, and also make the new valve more prone to fatigue and fracture. Moreover if full expansion of the stent is prone to deformation, the leaflet coaptation of the valve will be jeopardized.
  • [0020]
    Sadra et al (U.S. published application No. 20050137691) describes a system with two pieces, a valve piece and an anchor piece. The valve piece connects to the anchor piece in such a fashion that it will reduce the effective valve area considerably. Valve area, i.e., the inner diameter of the channel after the valve leaflets open, is of prime importance when considering an aortic valve replacement in a stenotic valve. Garrison's valve is also implanted in the inner portion of the stent, compromising the effective valve outflow area. Sadra et al's and Garrison's valves overlook this very critically important requirement.
  • [0021]
    The technologies described above and other technologies (for example, those disclosed in U.S. Pat. No. 4,908,028 to Colon et al.; U.S. Published Application No. 2003/0014104, U.S. Published Application No. 2003/0109924, U.S. Published Application No. 2005/0251251, U.S. Published Application No. 2005/0203616, and U.S. Pat. No. 6,908,481 to Cribier; U.S. Pat. No. 5,607,469 to Frey; U.S. Pat. No. 6,723,123 to Kazatchkov et al.; Germany Patent No. DE 3,128,704 A1 to Kuepper; U.S. Pat. No. 3,312,237 to Mon et a).; U.S. Published Application No. 2005/0182483 to Osbourne et al.; U.S. Pat. No. 1,306,391 to Romanoff; U.S. Published Application No. 2005/0203618 to Sharkcawy et al.; U.S. Published Application No. 2006/0052802 to Sterman et al.; U.S. Pat. No. 5,713,952; and U.S. Pat. No. 5,876,437 to Vanney et al.) also use various biological, or other synthetic materials for fabrication of the prosthetic valve. The duration of function and physical deterioration of these new valves have not been addressed. Their changeability has not been addressed, in the percutaneous situation.
  • [0022]
    It is to the solution of these and other problems that the present invention is directed.
  • SUMMARY OF THE INVENTION
  • [0023]
    It is accordingly a primary object of the present invention to provide to methods and apparatus for endovascularly replacing a heart valve.
  • [0024]
    In is another object of the present invention to provide methods and apparatus for endovascularly replacing a heart valve with a replacement valve prosthesis using a balloon expandable and/or self expanding valve cage stent upon which a bi-leaflet or tri-leaflet elastic valve is inserted.
  • [0025]
    It is also a feature of this invention that the valve piece of the implant is removable, and thus exchangeable, in the event of long or medium term failure of the implanted valve.
  • [0026]
    It is another object of this invention to provide maximal valve area to the out flow tract of the left ventricle, thus minimizing the gradient across the valve, by using a supra annular implant of the valve piece to the valve cage stent.
  • [0027]
    These and other objects are achieved by a heart valve prosthesis comprising a cylindrical valve cage stent constructed to be implanted percutaneously in the planar axis of a native valve annulus, the valve cage stent having a superior rim; and an elastic and compressible, multi-leaflet valve insertable percutaneously into the body, the valve including a valve frame made from a memory metal and a tissue cover attached to the valve frame; and attachment means for attaching the valve to the superior rim of the valve cage.
  • [0028]
    The valve can be a bi-leaflet or a tri-leaflet valve. The bi-leaflet valve includes a frame, a tissue cover, a deformable hinge, and means for detachably connecting the valve to the valve cage stent. The frame has two substantially semicircular, expandable, and compressible parts, and the tissue cover is configured to cover the two parts of the frame with the straight sides of the two parts in spaced-apart relation. The tissue cover has a central aperture and the two parts of the frame have respective slots. The deformable hinge has oppositely extending arms extending through the slots and a stem received through the aperture. The superior rim of the valve cage stent has a valve mount affixed thereto for receiving a mating part on the hinge, thereby defining the attachment means.
  • [0029]
    The tri-leaflet valve includes a frame, a tissue cover, and means for detachably connecting the valve to the valve cage stent. The frame is cylindrical and has three commissural posts mounted thereon. The tissue cover has three cusps fitted and sewn to the valve frame, the commissural posts being sized to maintain the commissural height of the cusps. The valve cage stent has three commissural pins extending from the superior rim thereof, and the commissural posts of the frame are cannulated to receive the commissural pins of the valve cage stent, thereby defining the attachment means.
  • [0030]
    Other objects, features and advantages of the present invention will be apparent to those skilled in the art upon a reading of this specification including the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0031]
    The invention is better understood by reading the following Detailed Description of the Preferred Embodiments with reference to the accompanying drawing figures, in which like reference numerals refer to like elements throughout, and in which:
  • [0032]
    FIG. 1 is a diagram of a valve prosthesis in accordance with the present invention.
  • [0033]
    FIG. 2A is a diagrammatic plan view of a frame for a bi-leaflet percutaneous heart valve in accordance with the present invention.
  • [0034]
    FIG. 2B is a diagrammatic plan view of a tissue cover for the frame of FIG. 2A.
  • [0035]
    FIG. 2C is a diagrammatic plan view of an assembled bi-leaflet percutaneous heart valve in accordance with the present invention, incorporating the frame of FIG. 2A and the tissue cover of FIG. 2B.
  • [0036]
    FIG. 2D is a diagrammatic side elevational view of the bi-leaflet percutaneous heart valve of FIG. 2C in the open position.
  • [0037]
    FIG. 2E is a diagrammatic side elevational view of the bi-leaflet percutaneous heart valve of FIG. 2C in the closed position.
  • [0038]
    FIG. 2F is a top perspective view of an assembled bi-leaflet percutaneous heart valve in accordance with the present invention, in the closed position.
  • [0039]
    FIGS. 2G and 2H are top and side perspective views of the bi-leaflet percutaneous heart valve of FIG. 2F in the open position.
  • [0040]
    FIGS. 2I and 2J are side perspective views of the valve cage stent for use with the bi-leaflet percutaneous heart valve of FIG. 2F.
  • [0041]
    FIG. 2K is a partial perspective view of the bi-leaflet percutaneous heart valve of FIG. 2F mounted on the valve cage stent of FIG. 2I, with the valve in the closed position.
  • [0042]
    FIG. 2L is a partial perspective view of the bi-leaflet percutaneous heart valve of FIG. 2F mounted on he valve cage stent of FIG. 2I, with the valve in the open position.
  • [0043]
    FIG. 3A is a diagrammatic perspective view of a frame for a tri-leaflet percutaneous heart valve in accordance with the present invention.
  • [0044]
    FIG. 3B is a perspective view of a tissue cover for the frame of FIG. 3A.
  • [0045]
    FIG. 3C is a perspective view of an assembled tri-leaflet percutaneous heart valve in accordance with the present invention, incorporating the frame of FIG. 3A and the tissue cover of FIG. 3B
  • [0046]
    FIG. 3D is a side perspective view of the valve cage stent for use with the tri-leaflet percutaneous heart valve of FIG. 3C.
  • [0047]
    FIGS. 3E and 3F are top perspective views of the valve cage stent for use with the tri-leaflet percutaneous heart valve of FIG. 3C.
  • [0048]
    FIG. 3G is a diagrammatic view of a portion the valve cage stent for use with the tri-leaflet percutaneous heart valve of FIG. 3C, which as been opened up and flattened for purposes of illustration.
  • [0049]
    FIG. 3H is a partially cut-away perspective view of the tri-leaflet percutaneous heart valve of FIG. 3C mounted on the valve cage stent of FIG. 3D, in the undeployed condition.
  • [0050]
    FIG. 3I is a partially cut-away perspective view of the tri-leaflet percutaneous heart valve of FIG. 3C mounted on the valve cage stent of FIG. 3D, in the deployed condition.
  • [0051]
    FIGS. 4A-4G show the sequence of steps in implantation of the bi-leaflet percutaneous heart valve prosthesis of FIG. 2C in an aorta, in which the valve is attached to the valve cage stent outside the delivery catheter.
  • [0052]
    FIGS. 5A-5I are diagrammatic representations of the sequence of steps in implantation of the bi-leaflet percutaneous heart valve of FIG. 2C, the aorta being omitted from all of FIGS. 5A-5I and the valve cage being omitted from FIGS. 5A-5F for clarity.
  • [0053]
    FIGS. 6A-6J show the sequence of steps in implantation of the tri-leaflet percutaneous heart valve of FIG. 3C in an aorta, in which the valve is attached to the valve cage stent outside the delivery catheter.
  • [0054]
    FIGS. 7A and 7B are exploded and assembled views, respectively, of the delivery system apparatus used in implantation of the bi-leaflet and tri-leaflet valves in accordance with the present invention.
  • [0055]
    FIG. 7C is an end view of the flexible sheath of the delivery system apparatus of FIGS. 7A and 7B.
  • [0056]
    FIG. 8 is a side view of a valve cage stent mounted on a balloon catheter.
  • [0057]
    FIGS. 9A-9T show the sequence of steps in implantation of the tri-leaflet percutaneous heart valve of FIG. 3C in an aorta, in which the valve is attached to the valve cage stent within the delivery catheter.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0058]
    In describing preferred embodiments of the present invention illustrated in the drawings, specific terminology is employed for the sake of clarity. However, the invention is not intended to be limited to the specific terminology so selected, and it is to be understood that each specific element includes all technical equivalents that operate in a similar manner to accomplish a similar purpose.
  • [0059]
    The present invention relates to heart valve prostheses that can be implanted percutaneously by means of a catheter from a remote location without opening the chest cavity. As shown in FIG. 1, the valve prosthesis 10 comprises two parts, (1) a valve cage stent 20 constructed to be implanted in the planar axis of the native valve annulus, (2) an elastic and compressible valve 30, and (3) an attachment mechanism for attaching the valve 30 to the superior rim of the above mentioned valve cage stent 20. In accordance with the present invention, two types 110 and 210 of heart valve prosthesis 10 are contemplated, one type 110 incorporating an elastic and compressible bi-leaflet hinged valve 130 (shown in FIGS. 2A-2E) and the other type 210 incorporating an elastic and compressible tri-leaflet biologic valve 230 (shown in FIGS. 3A-3C). A system and method for implanting the valves (shown in FIGS. 4A-4G, 5A-5I, and 6A-6J) is also encompassed by the invention.
  • [0060]
    Referring now to FIGS. 2A-2H, the bi-leaflet tissue valve 130 comprises a two-part (that is, a two-leaflet) frame 132 made from a memory metal wire or strip and a tissue cover 133. As best shown in FIG. 2A, each part 132 a and 132 b of the frame 132 is substantially semicircular. Portions of each part 132 a and 132 b of the frame 132 (for example, the straight side and the center portion of the curved side) are configured (for example, by having a sinusoidal configuration, shown by broken lines in FIGS. 2A and 2C) so that each part 132 a and 132 b of the frame 132, as well as the frame 132 as a whole, is expandable and compressible, while the remaining portions of the frame 132 are not expandable and compressible.
  • [0061]
    Each part 132 a and 132 b of the frame 132 includes a slot 134 for receiving a hinge 135 having a shape when deployed that is similar to a lower-case “t”, as shown in FIGS. 2D and 2E, having two aims 135 a and 135 b and a stem 135 c. The slot 134 is formed unitarily with the frame 132. The “t”-shaped hinge 135 is stamped out of memory metal (for example, nitinol) sheeting so that it is deformable. The arms 135 and 135 b of the hinge 135 have projections 135 d at their ends, which function as stops for the leaflets. The stem 135 c of the hinge 135 has a snap-on or screw-in mechanism 141 for attachment to a valve mount 142 (shown in FIGS. 2I-2L), as described below.
  • [0062]
    The tissue cover 133 (shown in FIG. 2B) is made, for example, of equine or bovine pericardium, or various synthetic materials, for example, or medical grade silicone, fabric, or other compressible, materials, and is configured to cover the two parts 132 a and 132 b of the frame 132 with their straight sides in spaced apart relation, with a central aperture 133 a in the center for receiving the stem of the “t”-shaped hinge 135 and two side apertures 133 b in alignment with the slots 134 for receiving the arms 135 a and 135 b of the hinge 135. The tissue cover 133 is sewn to each part 132 a and 132 b of the frame 132, as shown in FIGS. 2C and 2F-2H, and thus connects the two parts 132 a and 132 b of the frame 132 in spaced-apart relation.
  • [0063]
    As discussed in greater detail below, in use, the bi-leaflet valve 130 is detachably connected to a valve mount 142 (shown in FIGS. 2I and 21) via the “t”-shaped hinge 135, as shown in FIGS. 2K-2N, 4D-4G, and 5G-5I. The valve mount 142 is also made from a memory metal so that it is collapsible. More specifically, the valve mount 142 has arms 142 a and 142 b on either side of a receptacle 142 c, which are folded up vertically when the valve cage stent 120 is in its compressed (undeployed) condition, the ends of the arms 142 a and 142 b being affixed to the valve cage stent 120.
  • [0064]
    The detachable and collapsible bi-leaflet construction of the valve 130 enables the valve 130 in conjunction with its entire delivery system to be sized down so that it can be inserted percutaneously using a catheter, as described below.
  • [0065]
    Referring now to FIGS. 3A-3C, the tri-leaflet tissue valve 230 comprises an expandable and compressible valve frame 232 (shown in FIG. 3A) made from a memory metal wire or strip and a tissue cover 233 (shown in FIG. 3B and 3C). The tissue cover 233 is made from the individual cusps of a porcine aortic valve sewn to appropriate fabric. Three identical cusps are selected. Two or more pigs are used to get ideal sized aortic cusps. The muscle bar cusp is preferably not used; and all of the sinus and surrounding tissue is S discarded. The commissural height is maintained at all cost. The tissue cover 233 (that is, the cusps sewn to the fabric) is fitted and sewn to the valve frame 232. The valve frame 232 has three cannulated commissural posts 240 a, 240 b, and 240 c mounted thereon, and the tissue cover 233 is sewn to the commissural posts 240 a, 240 b, and 240 c to complete the tri-leaflet valve 230 (FIG. 3C).
  • [0066]
    As shown in FIGS. 3A-3C, the tri-leaflet valve 230 is mounted on commissural pins 240 aa, 240 bb, and 240 cc provided on a valve cage stent 220 of the type disclosed in provisional application No. 60/735,221, Attorney Docket P70721US0, which is incorporated herein by reference in its entirety. More specifically, the commissural posts 240 a, 240 b, and 240 c of the valve frame 232 are cannulated to receive the commissural pins 240 aa, 240 bb, and 240 cc, respectively, of the valve cage stent 220, thereby connecting the valve frame 232 (and thus the valve 230) to the valve cage stent 220. As described below, the heart valve prosthesis 210 incorporating the tri-leaflet valve 230 is delivered using a catheter.
  • [0067]
    As shown in FIG. 3G, the valve cage stent 220 for use with the tri-leaflet valve 230 has three different zones 221, 222, and 223 along its longitudinal axis, the different zones having different geometric configurations so as to perform different functions. The first, or center, zone 221 functions as the stent connector, which is identical to the stent disclosed in Int'al Patent Application No. PCT/US2006/043526, filed Nov. 9, 2006 (which is based on U.S. Provisional Application No. 60/735,221), and which connects to the native valve annulus. The second and third zones 222 and 223, at either end of the center zone 221, function respectively as the superior valve rim carrying the commissural pins in the tri-leaflet valve prosthesis 210 or the valve mount in the bi-leaflet valve prosthesis 110, and the inferior valve skirt. The valve skirt 223 provides additional support, as well as a fabric/tissue attachment area to minimize leaking.
  • [0068]
    The present invention also encompasses a system and method for implanting the above-described percutaneous valve prostheses 10 in the body. In a first embodiment, the system comprises a valve cage stent 20 for implantation in the body by the use of a first catheter of a delivery system 500 (shown in FIGS. 8A and 8B, and as described in greater detail hereinafter) to provide a stable, fixed, and sturdy frame within which an elastic, compressible valve 30 can be inserted and secured by a second catheter (not shown), and the valve 30 is attached to the valve cage stent 20 after they are discharged from their respective catheters. Performing the procedure in two parts at the same session downsizes the devices considerably, so that the procedure can be performed percutaneously. In a second embodiment, the system comprises a valve cage stent 20 and an elastic, compressible valve 30 which are inserted using the same catheter, and the valve 30 is attached to the valve cage stent 20 within the catheter, as shown in FIGS. 9A-9T.
  • [0069]
    The valve cage stent 20 is a self-expanding or balloon expandable cylindrical valve cage stent 20, made from memory metal, or stainless steel respectively. The self-expanding valve cage stent and the balloon expandable valve cage stent are structurally the same (that is, they differ only in the material from which they are made). The valve cage stent 20 is fabricated from metal tubing (memory metal or stainless steel), so that it is cylindrical in shape, with the stent pattern being cut into the tubing by laser.
  • [0070]
    The expansion of the valve cage stent 20 produces maximal foreshortening of the ovals in the mid portion of the stent and thus provides active fixation of the stent to the annulus of the valve being replaced. The valve cage stent 20 has a fabric covering on its interior and parts of its exterior surfaces so in its expanded state it forms a complete seal and does not allow any leakage of blood.
  • [0071]
    For delivery, the valve cage stent 20 is mounted on a balloon 600 (FIG. 8), or in a restraining sheath if self-expandable. The delivery system apparatus 500 is shown in FIGS. 7A-7C. The delivery system apparatus 500 comprises a flexible outer sheath 510, in which the valve cage stent 20 is inserted with a first set of guide wires 520 attached thereto, followed by a slotted nosecone 530 having another set of guide wires 540 attached thereto.
  • [0072]
    The valve cage stent 20 has provisions for the attachment of the prosthetic valve, depending on the type of prosthetic valve contemplated to be used. For example, in the case of a bi-leaflet valve, the valve is attached to the valve cage stent 120 via a valve mount affixed to the valve cage stent 120, as shown in FIGS. 4D-4G and 5G-5I. In the case of a tri-leaflet valve, the valve is attached to the valve cage stent 220 via engagement of the valve commissural posts 240 a, 240 b, and 240 c with the commissural pins 240 aa, 240 bb, and 240 cc of the valve cage stent 220, as shown in FIGS. 6H-6J.
  • [0073]
    The delivery system employs a two stage procedure, both stages of which can be performed at the same session, only minutes apart. The first stage is insertion of the valve cage stent 20. In the case of a bi-leaflet valve, as shown in FIG. 4A, the valve cage stent 120 has a valve mount connected thereto and a guide wire connected to the valve mount. In the case of a tri-leaflet valve, as shown in FIGS. 6A-6G and as described above, the valve cage stent 220 has three commissural pins 240 aa, 240 bb, and 240 cc provided thereon and guide wires connected thereto.
  • [0074]
    The second stage is insertion of the elastic and compressible valve, which is restrained in another catheter (not shown) for delivery into the valve cage stent 20. As shown in FIGS. 4A-4D, 5A-5F, and 6A-6H, in the second stage, the valve is placed over the guide wire (in the case of a bi-leaflet valve) or guide wires (in the case of the tri-leaflet valve) connected to the valve cage stent 20 in order to ensure proper positioning of the valve relative to the stent. Once the valve is seated, the guide wire or wires are withdrawn (FIGS. 4D-4G, 5G-5I, and 6I-6J).
  • [0075]
    Because the bi-leaflet valve is detachable from the valve mount, it can be replaced when necessary. The valve mount has a snap-on or screw-in mechanism for attachment of the “t”-shaped hinge 135 thereto, as well as the above-described guide wire attached to it for placement of the valve. The use of a valve cage 20 allows for fabrication of a tri-leaflet tissue valve.
  • [0076]
    In addition, the connection of valve 30 to the valve cage stent 20 provides the best effective flow dynamics, the flexibility of the whole system 500 is greatly increased, and the profile of the whole system 500 is reduced so that it can be inserted through a small opening in the access vessel.
  • [0077]
    Modifications and variations of the above-described embodiments of the present invention are possible, as appreciated by those skilled in the art in light of the above teachings. It is therefore to be understood that, within the scope of the appended claims and their equivalents, the invention may be practiced otherwise than as specifically described.

Claims (13)

1. A heart valve prosthesis comprising:
an expandable and compressible, cylindrical valve cage stent constructed to be implanted endovascularly in the planar axis of a native valve annulus, the valve cage stent having a superior rim;
an elastic and compressible, multi-leaflet valve insertable endovascularly into the body, the valve including an expandable and compressible valve frame and a tissue cover attached to the valve frame; and
attachment means for attaching the valve to the superior rim of the valve cage.
2. The heart valve prosthesis of claim 1, wherein the valve frame is made from a memory metal.
3. The heart valve prosthesis of claim 1, wherein:
the valve cage stent has a fabric covering on the interior surfaces thereof and on parts of the exterior surfaces thereof to provide a complete seal and prevent leakage of blood when the valve cage stent is expanded; and
the valve cage stent has first, second, and third zones along its longitudinal axis, the first zone being between the second and third zones, the first zone being configured to connect the valve cage stent to the native valve annulus, the second zone being configured as the superior valve rim, and the third zone being configured as an inferior valve skirt for providing additional support and as an attachment area for the fabric covering and surrounding tissue to minimize leaking.
4. The heart valve prosthesis of claim 1, wherein the valve is a bi-leaflet valve, the frame has two substantially semicircular, expandable, and compressible parts, and the tissue cover is configured to cover the two parts of the frame with the straight sides of the two parts in spaced-apart relation.
5. The heart valve prosthesis of claim 4, wherein the tissue cover has a central aperture and the two parts of the frame have respective slots, and wherein the heart valve prosthesis further comprises a deformable hinge having oppositely extending arms extending through the slots and a stem received through the aperture, and
wherein the attachment means comprises a valve mount affixed to the superior rim of the valve cage stent and a mating part on the hinge receivable in the valve mount.
6. The heart valve prosthesis of claim 5, wherein the oppositely extending arms of the hinge have stops at the ends thereof for limiting movement of the leaflets.
7. The heart valve prosthesis of claim 5, wherein the mating part on the hinge is removable from the valve mount, whereby the valve is replaceable.
8. The heart valve prosthesis of claim 1, wherein the valve is a tri-leaflet valve, the frame is cylindrical and has three commissural posts mounted thereon, the tissue cover has three cusps fitted and sewn to the valve frames, the commissural posts being sized to maintain the commissural height of the cusps.
9. The heart valve prosthesis of claim 8, wherein the valve cage stent has three commissural pins extending from the superior rim thereof, wherein the commissural posts of the frame are cannulated to receive the commissural pins of the valve cage stent, and wherein the commissural pins and the commissural posts define the attachment means.
10. The heart valve prosthesis of claim 8, wherein the tissue cover comprises fabric and three substantially identical aortic cusps affixed to the fabric.
11. A method for implanting the percutaneous valve prostheses of claim 1 in a body, comprising the steps of:
endovascularly inserting the valve cage stent in the planar axis of a native valve annulus; and
endovascularly attaching the valve to the superior rim of the valve cage stent so that the valve is in a supra annular position.
12. The method of claim 11, wherein the valve cage stent and the valve are inserted using respective catheters, and wherein the valve is attached to the valve cage stent after they are discharged from their respective catheters.
13. The method of claim 11, wherein the valve cage stent and the valve are inserted using the same catheter, and the valve is attached to the valve cage stent within the catheter.
US12309680 2006-07-28 2007-07-27 Percutaneous valve prosthesis and system and method for implanting same Pending US20090306768A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US83379106 true 2006-07-28 2006-07-28
US12309680 US20090306768A1 (en) 2006-07-28 2007-07-27 Percutaneous valve prosthesis and system and method for implanting same
PCT/US2007/016855 WO2008013915A9 (en) 2006-07-28 2007-07-27 Percutaneous valve prosthesis and system and method for implanting same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12309680 US20090306768A1 (en) 2006-07-28 2007-07-27 Percutaneous valve prosthesis and system and method for implanting same

Publications (1)

Publication Number Publication Date
US20090306768A1 true true US20090306768A1 (en) 2009-12-10

Family

ID=38982087

Family Applications (2)

Application Number Title Priority Date Filing Date
US12309680 Pending US20090306768A1 (en) 2006-07-28 2007-07-27 Percutaneous valve prosthesis and system and method for implanting same
US15221435 Pending US20160331532A1 (en) 2006-07-28 2016-07-27 Percutaneous valve prosthesis and system and method for implanting the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15221435 Pending US20160331532A1 (en) 2006-07-28 2016-07-27 Percutaneous valve prosthesis and system and method for implanting the same

Country Status (2)

Country Link
US (2) US20090306768A1 (en)
WO (1) WO2008013915A9 (en)

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090216314A1 (en) * 2005-11-10 2009-08-27 Arshad Quadri Balloon-Expandable, Self-Expanding, Vascular Prosthesis Connecting Stent
US20090281618A1 (en) * 2008-04-23 2009-11-12 Medtronic, Inc. Prosthetic Heart Valve Devices and Methods of Valve Replacement
US20100036479A1 (en) * 2008-04-23 2010-02-11 Medtronic, Inc. Stented Heart Valve Devices
US20100082089A1 (en) * 2008-10-01 2010-04-01 Arshad Quadri Delivery system for vascular implant
US20100082094A1 (en) * 2008-09-29 2010-04-01 Arshad Quadri Heart valve
US20100185275A1 (en) * 2009-01-12 2010-07-22 Valve Medical Ltd. Modular percutaneous valve structure and delivery method
WO2012004679A2 (en) 2010-07-09 2012-01-12 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
US8414644B2 (en) 2009-04-15 2013-04-09 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US8628571B1 (en) 2012-11-13 2014-01-14 Mitraltech Ltd. Percutaneously-deliverable mechanical valve
US8652203B2 (en) 2010-09-23 2014-02-18 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US8852272B2 (en) 2011-08-05 2014-10-07 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US8992604B2 (en) 2010-07-21 2015-03-31 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9017399B2 (en) 2010-07-21 2015-04-28 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US20150164636A1 (en) * 2013-12-17 2015-06-18 Michael G. Valdez Inverted valve structure
US9138335B2 (en) 2006-07-31 2015-09-22 Syntheon Cardiology, Llc Surgical implant devices and methods for their manufacture and use
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
US9345573B2 (en) * 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US9364354B2 (en) 2000-03-27 2016-06-14 Neovasc Medical Ltd Methods for treating abnormal growths in the body using a flow reducing implant
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9480560B2 (en) 2009-09-29 2016-11-01 Edwards Lifesciences Cardiaq Llc Method of securing an intralumenal frame assembly
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US9572662B2 (en) 2011-06-21 2017-02-21 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9579193B2 (en) 2010-09-23 2017-02-28 Transmural Systems Llc Methods and systems for delivering prostheses using rail techniques
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9681952B2 (en) 2013-01-24 2017-06-20 Mitraltech Ltd. Anchoring of prosthetic valve supports
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9724083B2 (en) 2013-07-26 2017-08-08 Edwards Lifesciences Cardiaq Llc Systems and methods for sealing openings in an anatomical wall
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9744059B2 (en) 2003-11-19 2017-08-29 Neovasc Medical Ltd. Vascular implant
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9770331B2 (en) 2010-12-23 2017-09-26 Twelve, Inc. System for mitral valve repair and replacement
US9788941B2 (en) 2010-03-10 2017-10-17 Mitraltech Ltd. Axially-shortening prosthetic valve
USD800908S1 (en) 2016-08-10 2017-10-24 Mitraltech Ltd. Prosthetic valve element

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant

Citations (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168616A (en) *
US1306391A (en) * 1918-02-09 1919-06-10 Hippolyte Romanoff Valve.
US3312237A (en) * 1964-05-06 1967-04-04 Mon George Bicuspid heart valve
US4908028A (en) * 1987-03-20 1990-03-13 Jean Colon Valve incorporating at least one rocking flap with respect to elastic pivots
US5397355A (en) * 1994-07-19 1995-03-14 Stentco, Inc. Intraluminal stent
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5509930A (en) * 1993-12-17 1996-04-23 Autogenics Stentless heart valve
US5607469A (en) * 1993-10-28 1997-03-04 Inocor Gmbh Bi-leaflet prosthetic heart valve
US5713952A (en) * 1995-09-11 1998-02-03 St. Jude Medical, Inc. Apparatus for attachment of heart valve holder to heart valve prosthesis
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US5879381A (en) * 1996-03-10 1999-03-09 Terumo Kabushiki Kaisha Expandable stent for implanting in a body
US5935108A (en) * 1997-11-14 1999-08-10 Reflow, Inc. Recanalization apparatus and devices for use therein and method
US6015431A (en) * 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US6053940A (en) * 1995-10-20 2000-04-25 Wijay; Bandula Vascular stent
US6168616B1 (en) * 1997-06-02 2001-01-02 Global Vascular Concepts Manually expandable stent
US6168614B1 (en) * 1990-05-18 2001-01-02 Heartport, Inc. Valve prosthesis for implantation in the body
US20020032481A1 (en) * 2000-09-12 2002-03-14 Shlomo Gabbay Heart valve prosthesis and sutureless implantation of a heart valve prosthesis
US6425916B1 (en) * 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US6517573B1 (en) * 2000-04-11 2003-02-11 Endovascular Technologies, Inc. Hook for attaching to a corporeal lumen and method of manufacturing
US6527800B1 (en) * 2000-06-26 2003-03-04 Rex Medical, L.P. Vascular device and method for valve leaflet apposition
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
US20040039436A1 (en) * 2001-10-11 2004-02-26 Benjamin Spenser Implantable prosthetic valve
US6723123B1 (en) * 1999-11-10 2004-04-20 Impsa International Incorporated Prosthetic heart valve
US6733523B2 (en) * 1998-12-11 2004-05-11 Endologix, Inc. Implantable vascular graft
US20040102842A1 (en) * 2000-09-19 2004-05-27 Josef Jansen Prosthetic mitral heart valve
US6767362B2 (en) * 2000-04-06 2004-07-27 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US20050096738A1 (en) * 2003-10-06 2005-05-05 Cali Douglas S. Minimally invasive valve replacement system
US6908481B2 (en) * 1996-12-31 2005-06-21 Edwards Lifesciences Pvt, Inc. Value prosthesis for implantation in body channels
US20050137687A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Heart valve anchor and method
US20050137690A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Low profile heart valve and delivery system
US20050137691A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Two piece heart valve and anchor
US20050137682A1 (en) * 2003-12-22 2005-06-23 Henri Justino Stent mounted valve
US20050137701A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Locking heart valve anchor
US20050182483A1 (en) * 2004-02-11 2005-08-18 Cook Incorporated Percutaneously placed prosthesis with thromboresistant valve portion
US20060052802A1 (en) * 1992-12-03 2006-03-09 Sterman Wesley D Devices and methods for intracardiac procedures
US20060058872A1 (en) * 2003-12-23 2006-03-16 Amr Salahieh Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US7018401B1 (en) * 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US7018406B2 (en) * 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US20060106454A1 (en) * 2004-10-29 2006-05-18 Osborne Thomas A Intraluminal medical device with cannula for controlled retrograde flow
US20060149360A1 (en) * 2003-07-08 2006-07-06 Ventor Technologies Ltd. Fluid flow prosthetic device
US20060195183A1 (en) * 2005-02-18 2006-08-31 The Cleveland Clinic Foundation Apparatus and methods for replacing a cardiac valve
US20070010876A1 (en) * 2003-12-23 2007-01-11 Amr Salahieh Externally Expandable Heart Valve Anchor and Method
US20070016286A1 (en) * 2003-07-21 2007-01-18 Herrmann Howard C Percutaneous heart valve
US7186265B2 (en) * 2003-12-10 2007-03-06 Medtronic, Inc. Prosthetic cardiac valves and systems and methods for implanting thereof
US20070067016A1 (en) * 2003-09-16 2007-03-22 Johannes Jung Stent comprising terminal anchoring elements
US20070118206A1 (en) * 1998-03-31 2007-05-24 Boston Scientific Scimed, Inc. Low profile medical stent
US20070162107A1 (en) * 2003-12-23 2007-07-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20080021546A1 (en) * 2006-07-18 2008-01-24 Tim Patz System for deploying balloon-expandable heart valves
US20080071363A1 (en) * 2006-09-19 2008-03-20 Yosi Tuval Valve prosthesis fixation techniques using sandwiching
US20080125859A1 (en) * 2003-12-23 2008-05-29 Sadra Medical, Inc. Methods and Apparatus for Endovascularly Replacing a Patient's Heart Valve
US20080140189A1 (en) * 2006-12-06 2008-06-12 Corevalve, Inc. System and method for transapical delivery of an annulus anchored self-expanding valve
US20080147183A1 (en) * 2006-12-14 2008-06-19 Mikolaj Styrc Endovalve
US20080177381A1 (en) * 2007-01-19 2008-07-24 The Cleveland Clinic Foundation Method for implanting a cardiovascular valve
US20080208328A1 (en) * 2007-02-23 2008-08-28 Endovalve, Inc. Systems and Methods For Placement of Valve Prosthesis System
US20090005863A1 (en) * 2006-02-16 2009-01-01 Goetz Wolfgang Minimally invasive heart valve replacement
US20090054976A1 (en) * 2007-08-20 2009-02-26 Yosi Tuval Stent loading tool and method for use thereof
US20090076585A1 (en) * 2007-09-14 2009-03-19 William Cook Europe Device for loading a self-expandable prosthesis into a sheath
US20090076598A1 (en) * 2004-06-16 2009-03-19 Amr Salahieh Everting Heart Valve
US20090138079A1 (en) * 2007-10-10 2009-05-28 Vector Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US20090163934A1 (en) * 1999-04-09 2009-06-25 Evalve, Inc. Detachment mechanism for implantable fixation devices
US20090182407A1 (en) * 2008-01-14 2009-07-16 Boston Scientific Scimed, Inc. Luer or clamp-type suture release apparatus and method for loading and delivering a stent
US20090192601A1 (en) * 2008-01-24 2009-07-30 Medtronic Vascular, Inc. Infundibular Reducer Device Delivery System and Related Methods
US20090216314A1 (en) * 2005-11-10 2009-08-27 Arshad Quadri Balloon-Expandable, Self-Expanding, Vascular Prosthesis Connecting Stent
US20100004740A1 (en) * 1999-11-17 2010-01-07 Jacques Seguin Prosthetic Valve for Transluminal Delivery
US20100036479A1 (en) * 2008-04-23 2010-02-11 Medtronic, Inc. Stented Heart Valve Devices
US20100082094A1 (en) * 2008-09-29 2010-04-01 Arshad Quadri Heart valve
US20100082089A1 (en) * 2008-10-01 2010-04-01 Arshad Quadri Delivery system for vascular implant
US20100179647A1 (en) * 2006-09-11 2010-07-15 Carpenter Judith T Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure
US7871435B2 (en) * 2004-01-23 2011-01-18 Edwards Lifesciences Corporation Anatomically approximate prosthetic mitral heart valve
US20110022157A1 (en) * 2007-10-25 2011-01-27 Jacques Essinger Stents, Valved-Stents, and Methods and Systems for Delivery Thereof
US20110022165A1 (en) * 2009-07-23 2011-01-27 Edwards Lifesciences Corporation Introducer for prosthetic heart valve
US20110178597A9 (en) * 2006-02-18 2011-07-21 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
US20120022639A1 (en) * 2010-07-21 2012-01-26 Hacohen Gil Guide wires with commissural anchors to advance a prosthetic valve
US20120078353A1 (en) * 2010-09-23 2012-03-29 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US8236045B2 (en) * 2006-12-22 2012-08-07 Edwards Lifesciences Corporation Implantable prosthetic valve assembly and method of making the same
US20120215303A1 (en) * 2009-09-29 2012-08-23 Cardiaq Valve Technologies, Inc. Replacement heart valve and method
US8361537B2 (en) * 1998-03-30 2013-01-29 Innovational Holdings, Llc Expandable medical device with beneficial agent concentration gradient
US8414645B2 (en) * 2009-08-27 2013-04-09 Medtronic, Inc. Transcatheter valve delivery systems and methods
US8449599B2 (en) * 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US20130138207A1 (en) * 2009-04-15 2013-05-30 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US8470023B2 (en) * 2007-02-05 2013-06-25 Boston Scientific Scimed, Inc. Percutaneous valve, system, and method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482228B1 (en) * 2000-11-14 2002-11-19 Troy R. Norred Percutaneous aortic valve replacement

Patent Citations (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168614A (en) *
US6168616A (en) *
US1306391A (en) * 1918-02-09 1919-06-10 Hippolyte Romanoff Valve.
US3312237A (en) * 1964-05-06 1967-04-04 Mon George Bicuspid heart valve
US4908028A (en) * 1987-03-20 1990-03-13 Jean Colon Valve incorporating at least one rocking flap with respect to elastic pivots
US6582462B1 (en) * 1990-05-18 2003-06-24 Heartport, Inc. Valve prosthesis for implantation in the body and a catheter for implanting such valve prosthesis
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US6168614B1 (en) * 1990-05-18 2001-01-02 Heartport, Inc. Valve prosthesis for implantation in the body
US20060052802A1 (en) * 1992-12-03 2006-03-09 Sterman Wesley D Devices and methods for intracardiac procedures
US5607469A (en) * 1993-10-28 1997-03-04 Inocor Gmbh Bi-leaflet prosthetic heart valve
US5509930A (en) * 1993-12-17 1996-04-23 Autogenics Stentless heart valve
US5397355A (en) * 1994-07-19 1995-03-14 Stentco, Inc. Intraluminal stent
US5876437A (en) * 1995-09-11 1999-03-02 St. Jude Medical, Inc. Apparatus for attachment of heart valve holder to heart valve prosthesis
US5713952A (en) * 1995-09-11 1998-02-03 St. Jude Medical, Inc. Apparatus for attachment of heart valve holder to heart valve prosthesis
US6053940A (en) * 1995-10-20 2000-04-25 Wijay; Bandula Vascular stent
US5879381A (en) * 1996-03-10 1999-03-09 Terumo Kabushiki Kaisha Expandable stent for implanting in a body
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US6015431A (en) * 1996-12-23 2000-01-18 Prograft Medical, Inc. Endolumenal stent-graft with leak-resistant seal
US6908481B2 (en) * 1996-12-31 2005-06-21 Edwards Lifesciences Pvt, Inc. Value prosthesis for implantation in body channels
US6168616B1 (en) * 1997-06-02 2001-01-02 Global Vascular Concepts Manually expandable stent
US5935108A (en) * 1997-11-14 1999-08-10 Reflow, Inc. Recanalization apparatus and devices for use therein and method
US8361537B2 (en) * 1998-03-30 2013-01-29 Innovational Holdings, Llc Expandable medical device with beneficial agent concentration gradient
US20070118206A1 (en) * 1998-03-31 2007-05-24 Boston Scientific Scimed, Inc. Low profile medical stent
US6733523B2 (en) * 1998-12-11 2004-05-11 Endologix, Inc. Implantable vascular graft
US7018401B1 (en) * 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6425916B1 (en) * 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US20090163934A1 (en) * 1999-04-09 2009-06-25 Evalve, Inc. Detachment mechanism for implantable fixation devices
US6723123B1 (en) * 1999-11-10 2004-04-20 Impsa International Incorporated Prosthetic heart valve
US20100004740A1 (en) * 1999-11-17 2010-01-07 Jacques Seguin Prosthetic Valve for Transluminal Delivery
US20080133003A1 (en) * 1999-11-17 2008-06-05 Jacques Seguin Prosthetic valve for transluminal delivery
US7018406B2 (en) * 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US7329278B2 (en) * 1999-11-17 2008-02-12 Corevalve, Inc. Prosthetic valve for transluminal delivery
US6767362B2 (en) * 2000-04-06 2004-07-27 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US6517573B1 (en) * 2000-04-11 2003-02-11 Endovascular Technologies, Inc. Hook for attaching to a corporeal lumen and method of manufacturing
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
US6527800B1 (en) * 2000-06-26 2003-03-04 Rex Medical, L.P. Vascular device and method for valve leaflet apposition
US20020032481A1 (en) * 2000-09-12 2002-03-14 Shlomo Gabbay Heart valve prosthesis and sutureless implantation of a heart valve prosthesis
US20040102842A1 (en) * 2000-09-19 2004-05-27 Josef Jansen Prosthetic mitral heart valve
US6780200B2 (en) * 2000-09-19 2004-08-24 Adiam Life Science Ag Prosthetic mitral heart valve
US20040039436A1 (en) * 2001-10-11 2004-02-26 Benjamin Spenser Implantable prosthetic valve
US20060149360A1 (en) * 2003-07-08 2006-07-06 Ventor Technologies Ltd. Fluid flow prosthetic device
US7201772B2 (en) * 2003-07-08 2007-04-10 Ventor Technologies, Ltd. Fluid flow prosthetic device
US20070016286A1 (en) * 2003-07-21 2007-01-18 Herrmann Howard C Percutaneous heart valve
US20070067016A1 (en) * 2003-09-16 2007-03-22 Johannes Jung Stent comprising terminal anchoring elements
US20050096738A1 (en) * 2003-10-06 2005-05-05 Cali Douglas S. Minimally invasive valve replacement system
US7186265B2 (en) * 2003-12-10 2007-03-06 Medtronic, Inc. Prosthetic cardiac valves and systems and methods for implanting thereof
US20050137682A1 (en) * 2003-12-22 2005-06-23 Henri Justino Stent mounted valve
US20050137691A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Two piece heart valve and anchor
US20070010876A1 (en) * 2003-12-23 2007-01-11 Amr Salahieh Externally Expandable Heart Valve Anchor and Method
US20060253191A1 (en) * 2003-12-23 2006-11-09 Amr Salahieh Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US20060058872A1 (en) * 2003-12-23 2006-03-16 Amr Salahieh Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements
US20050137695A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Replacement valve and anchor
US20050137701A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Locking heart valve anchor
US20070162107A1 (en) * 2003-12-23 2007-07-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20050137687A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Heart valve anchor and method
US20080125859A1 (en) * 2003-12-23 2008-05-29 Sadra Medical, Inc. Methods and Apparatus for Endovascularly Replacing a Patient's Heart Valve
US20050137690A1 (en) * 2003-12-23 2005-06-23 Sadra Medical Low profile heart valve and delivery system
US7381219B2 (en) * 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US7871435B2 (en) * 2004-01-23 2011-01-18 Edwards Lifesciences Corporation Anatomically approximate prosthetic mitral heart valve
US20050182483A1 (en) * 2004-02-11 2005-08-18 Cook Incorporated Percutaneously placed prosthesis with thromboresistant valve portion
US20090076598A1 (en) * 2004-06-16 2009-03-19 Amr Salahieh Everting Heart Valve
US20060106454A1 (en) * 2004-10-29 2006-05-18 Osborne Thomas A Intraluminal medical device with cannula for controlled retrograde flow
US20060195183A1 (en) * 2005-02-18 2006-08-31 The Cleveland Clinic Foundation Apparatus and methods for replacing a cardiac valve
US20120179239A1 (en) * 2005-11-10 2012-07-12 Cardiaq Valve Technologies, Inc. Vascular prosthesis connecting stent
US20090216314A1 (en) * 2005-11-10 2009-08-27 Arshad Quadri Balloon-Expandable, Self-Expanding, Vascular Prosthesis Connecting Stent
US20130138203A1 (en) * 2005-11-10 2013-05-30 Cardiaq Valve Technologies, Inc. Prosthesis having a plurality of distal and proximal prongs
US20090005863A1 (en) * 2006-02-16 2009-01-01 Goetz Wolfgang Minimally invasive heart valve replacement
US20110178597A9 (en) * 2006-02-18 2011-07-21 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
US20080021546A1 (en) * 2006-07-18 2008-01-24 Tim Patz System for deploying balloon-expandable heart valves
US20100179647A1 (en) * 2006-09-11 2010-07-15 Carpenter Judith T Methods of reducing embolism to cerebral circulation as a consequence of an index cardiac procedure
US20080071369A1 (en) * 2006-09-19 2008-03-20 Yosi Tuval Valve fixation member having engagement arms
US20080071363A1 (en) * 2006-09-19 2008-03-20 Yosi Tuval Valve prosthesis fixation techniques using sandwiching
US20080140189A1 (en) * 2006-12-06 2008-06-12 Corevalve, Inc. System and method for transapical delivery of an annulus anchored self-expanding valve
US20080147183A1 (en) * 2006-12-14 2008-06-19 Mikolaj Styrc Endovalve
US8236045B2 (en) * 2006-12-22 2012-08-07 Edwards Lifesciences Corporation Implantable prosthetic valve assembly and method of making the same
US20080177381A1 (en) * 2007-01-19 2008-07-24 The Cleveland Clinic Foundation Method for implanting a cardiovascular valve
US8470023B2 (en) * 2007-02-05 2013-06-25 Boston Scientific Scimed, Inc. Percutaneous valve, system, and method
US20080208328A1 (en) * 2007-02-23 2008-08-28 Endovalve, Inc. Systems and Methods For Placement of Valve Prosthesis System
US20090054976A1 (en) * 2007-08-20 2009-02-26 Yosi Tuval Stent loading tool and method for use thereof
US20090076585A1 (en) * 2007-09-14 2009-03-19 William Cook Europe Device for loading a self-expandable prosthesis into a sheath
US20090138079A1 (en) * 2007-10-10 2009-05-28 Vector Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US20110022157A1 (en) * 2007-10-25 2011-01-27 Jacques Essinger Stents, Valved-Stents, and Methods and Systems for Delivery Thereof
US20090182407A1 (en) * 2008-01-14 2009-07-16 Boston Scientific Scimed, Inc. Luer or clamp-type suture release apparatus and method for loading and delivering a stent
US20090192601A1 (en) * 2008-01-24 2009-07-30 Medtronic Vascular, Inc. Infundibular Reducer Device Delivery System and Related Methods
US20100036479A1 (en) * 2008-04-23 2010-02-11 Medtronic, Inc. Stented Heart Valve Devices
US20130131788A1 (en) * 2008-09-29 2013-05-23 Cardiaq Valve Technologies, Inc. Body cavity prosthesis
US20100082094A1 (en) * 2008-09-29 2010-04-01 Arshad Quadri Heart valve
US20130184813A1 (en) * 2008-09-29 2013-07-18 Cardiaq Valve Technologies, Inc. Body cavity prosthesis
US20130131793A1 (en) * 2008-09-29 2013-05-23 Cardiaq Valve Technologies, Inc. Replacement heart valve and method
US20100082089A1 (en) * 2008-10-01 2010-04-01 Arshad Quadri Delivery system for vascular implant
US20130144380A1 (en) * 2009-04-15 2013-06-06 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US20140172086A1 (en) * 2009-04-15 2014-06-19 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US20130138207A1 (en) * 2009-04-15 2013-05-30 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US20140172085A1 (en) * 2009-04-15 2014-06-19 Cardiaq Valve Technologies, Inc. Vascular implant
US20110022165A1 (en) * 2009-07-23 2011-01-27 Edwards Lifesciences Corporation Introducer for prosthetic heart valve
US8414645B2 (en) * 2009-08-27 2013-04-09 Medtronic, Inc. Transcatheter valve delivery systems and methods
US20120215303A1 (en) * 2009-09-29 2012-08-23 Cardiaq Valve Technologies, Inc. Replacement heart valve and method
US20130144378A1 (en) * 2009-09-29 2013-06-06 Cardiaq Valve Technologies, Inc. Method of securing an intralumenal frame assembly
US20130144381A1 (en) * 2009-09-29 2013-06-06 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US8449599B2 (en) * 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US20120022639A1 (en) * 2010-07-21 2012-01-26 Hacohen Gil Guide wires with commissural anchors to advance a prosthetic valve
US20120078353A1 (en) * 2010-09-23 2012-03-29 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods

Cited By (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9364354B2 (en) 2000-03-27 2016-06-14 Neovasc Medical Ltd Methods for treating abnormal growths in the body using a flow reducing implant
US9744059B2 (en) 2003-11-19 2017-08-29 Neovasc Medical Ltd. Vascular implant
US9433514B2 (en) 2005-11-10 2016-09-06 Edwards Lifesciences Cardiaq Llc Method of securing a prosthesis
US20090216314A1 (en) * 2005-11-10 2009-08-27 Arshad Quadri Balloon-Expandable, Self-Expanding, Vascular Prosthesis Connecting Stent
US8092520B2 (en) 2005-11-10 2012-01-10 CardiAQ Technologies, Inc. Vascular prosthesis connecting stent
US9486336B2 (en) 2005-11-10 2016-11-08 Edwards Lifesciences Cardiaq Llc Prosthesis having a plurality of distal and proximal prongs
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9138335B2 (en) 2006-07-31 2015-09-22 Syntheon Cardiology, Llc Surgical implant devices and methods for their manufacture and use
US9173737B2 (en) 2008-04-23 2015-11-03 Medtronic, Inc. Stented heart valve devices
US8323336B2 (en) 2008-04-23 2012-12-04 Medtronic, Inc. Prosthetic heart valve devices and methods of valve replacement
US20090281618A1 (en) * 2008-04-23 2009-11-12 Medtronic, Inc. Prosthetic Heart Valve Devices and Methods of Valve Replacement
US20100036479A1 (en) * 2008-04-23 2010-02-11 Medtronic, Inc. Stented Heart Valve Devices
US8403983B2 (en) 2008-09-29 2013-03-26 Cardiaq Valve Technologies, Inc. Heart valve
US20100082094A1 (en) * 2008-09-29 2010-04-01 Arshad Quadri Heart valve
US9456896B2 (en) 2008-09-29 2016-10-04 Edwards Lifesciences Cardiaq Llc Body cavity prosthesis
US9339377B2 (en) 2008-09-29 2016-05-17 Edwards Lifesciences Cardiaq Llc Body cavity prosthesis
US8894702B2 (en) 2008-09-29 2014-11-25 Cardiaq Valve Technologies, Inc. Replacement heart valve and method
US8337541B2 (en) 2008-10-01 2012-12-25 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US8911455B2 (en) 2008-10-01 2014-12-16 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US20100082089A1 (en) * 2008-10-01 2010-04-01 Arshad Quadri Delivery system for vascular implant
US9597183B2 (en) 2008-10-01 2017-03-21 Edwards Lifesciences Cardiaq Llc Delivery system for vascular implant
US20100185275A1 (en) * 2009-01-12 2010-07-22 Valve Medical Ltd. Modular percutaneous valve structure and delivery method
US9402720B2 (en) 2009-01-12 2016-08-02 Valve Medical Ltd. Modular percutaneous valve structure and delivery method
US9333074B2 (en) 2009-04-15 2016-05-10 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US9339378B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US8795356B2 (en) 2009-04-15 2014-08-05 Cardiaq Valve Technologies, Inc. Vascular implant
US9339380B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant
US9585747B2 (en) 2009-04-15 2017-03-07 Edwards Lifesciences Cardiaq Llc Vascular implant
US8414644B2 (en) 2009-04-15 2013-04-09 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US9333073B2 (en) 2009-04-15 2016-05-10 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery method
US9339379B2 (en) 2009-04-15 2016-05-17 Edwards Lifesciences Cardiaq Llc Vascular implant and delivery system
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9023100B2 (en) 2009-09-29 2015-05-05 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
US9480560B2 (en) 2009-09-29 2016-11-01 Edwards Lifesciences Cardiaq Llc Method of securing an intralumenal frame assembly
US9788941B2 (en) 2010-03-10 2017-10-17 Mitraltech Ltd. Axially-shortening prosthetic valve
US9248014B2 (en) 2010-05-05 2016-02-02 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9770329B2 (en) 2010-05-05 2017-09-26 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US9241790B2 (en) 2010-05-05 2016-01-26 Neovasc Tiara Inc. Transcatheter mitral valve prosthesis
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
WO2012004679A2 (en) 2010-07-09 2012-01-12 Highlife Sas Transcatheter atrio-ventricular valve prosthesis
EP2962664A1 (en) 2010-07-09 2016-01-06 Highlife SAS Transcatheter atrio-ventricular valve prosthesis
DE112011102305T5 (en) 2010-07-09 2013-05-16 Highlife Sas Transcatheter atrioventricular valve prosthesis
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US8992604B2 (en) 2010-07-21 2015-03-31 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9017399B2 (en) 2010-07-21 2015-04-28 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9579193B2 (en) 2010-09-23 2017-02-28 Transmural Systems Llc Methods and systems for delivering prostheses using rail techniques
US8652203B2 (en) 2010-09-23 2014-02-18 Cardiaq Valve Technologies, Inc. Replacement heart valves, delivery devices and methods
US9770331B2 (en) 2010-12-23 2017-09-26 Twelve, Inc. System for mitral valve repair and replacement
US9713529B2 (en) 2011-04-28 2017-07-25 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9572662B2 (en) 2011-06-21 2017-02-21 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9579196B2 (en) 2011-06-21 2017-02-28 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9585751B2 (en) 2011-06-21 2017-03-07 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US9387078B2 (en) 2011-08-05 2016-07-12 Mitraltech Ltd. Percutaneous mitral valve replacement and sealing
US8852272B2 (en) 2011-08-05 2014-10-07 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US9345573B2 (en) * 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US8628571B1 (en) 2012-11-13 2014-01-14 Mitraltech Ltd. Percutaneously-deliverable mechanical valve
US9498332B2 (en) 2012-11-13 2016-11-22 Mitraltech Ltd. Percutaneously-deliverable mechanical valve
US9681952B2 (en) 2013-01-24 2017-06-20 Mitraltech Ltd. Anchoring of prosthetic valve supports
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US9724083B2 (en) 2013-07-26 2017-08-08 Edwards Lifesciences Cardiaq Llc Systems and methods for sealing openings in an anatomical wall
US20150164636A1 (en) * 2013-12-17 2015-06-18 Michael G. Valdez Inverted valve structure
USD755384S1 (en) 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
USD800908S1 (en) 2016-08-10 2017-10-24 Mitraltech Ltd. Prosthetic valve element

Also Published As

Publication number Publication date Type
WO2008013915A3 (en) 2008-07-03 application
WO2008013915A9 (en) 2008-08-21 application
WO2008013915A2 (en) 2008-01-31 application
US20160331532A1 (en) 2016-11-17 application

Similar Documents

Publication Publication Date Title
US6458153B1 (en) Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US8313525B2 (en) Valve suturing and implantation procedures
EP1570809B1 (en) Cardiac-valve prosthesis
US7621948B2 (en) Percutaneous heart valve
US8323336B2 (en) Prosthetic heart valve devices and methods of valve replacement
US7959672B2 (en) Replacement valve and anchor
US8137398B2 (en) Prosthetic valve having tapered tip when compressed for delivery
US20050137688A1 (en) Repositionable heart valve and method
US7399315B2 (en) Minimally-invasive heart valve with cusp positioners
US7025780B2 (en) Valvular prosthesis
US8080054B2 (en) Implantable prosthetic valve with non-laminar flow
US8771345B2 (en) Valve prosthesis fixation techniques using sandwiching
US20120078357A1 (en) Prosthetic Heart Valve Frame With Flexible Commissures
US6767362B2 (en) Minimally-invasive heart valves and methods of use
US7972378B2 (en) Stents for prosthetic heart valves
US8308798B2 (en) Quick-connect prosthetic heart valve and methods
US8070800B2 (en) Transcatheter heart valve prostheses
US8500798B2 (en) Rapid deployment prosthetic heart valve
US8414645B2 (en) Transcatheter valve delivery systems and methods
US8834563B2 (en) Expandable prosthetic valve having anchoring appendages
US20100249894A1 (en) Prosthetic heart valve system
US7708775B2 (en) Methods for rapid deployment of prosthetic heart valves
US20090099653A1 (en) Expandable valve prosthesis with sealing mechanism
US20120035722A1 (en) Mitral Prosthesis and Methods for Implantation
US20090138079A1 (en) Prosthetic heart valve for transfemoral delivery

Legal Events

Date Code Title Description
AS Assignment

Owner name: CARDIAQ VALVE TECHNOLOGIES, INC., MAINE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:QUADRI, ARSHAD;REEL/FRAME:023123/0062

Effective date: 20090623

AS Assignment

Owner name: EDWARDS LIFESCIENCES CARDIAQ, INC., CALIFORNIA

Free format text: MERGER AND CHANGE OF NAME;ASSIGNORS:IMPALA, INC.;CARDIAQ VALVE TECHNOLOGIES, INC.,;CARDIAQ VALVE TECHNOLOGIES, INC.;REEL/FRAME:037228/0792

Effective date: 20150826

AS Assignment

Owner name: EDWARDS LIFESCIENCES CARDIAQ LLC, CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:EDWARDS LIFESCIENCES CARDIAQ, INC.;REEL/FRAME:037485/0377

Effective date: 20151210